SSG
Summit Securities Group Portfolio holdings
AUM
$280M
1-Year Return
13.47%
This Quarter Return
-0.08%
1 Year Return
+13.47%
3 Year Return
+33.41%
5 Year Return
+89.54%
10 Year Return
+225.55%
AUM
$144M
AUM Growth
-$124M
(-46%)
Cap. Flow
-$119M
Cap. Flow
% of AUM
-82.86%
Top 10 Holdings %
Top 10 Hldgs %
48.79%
Holding
1,004
New
477
Increased
73
Reduced
66
Closed
332
Top Buys
| 1 |
Apple
AAPL
|
+$19.1M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$10.6M |
| 3 |
ArcelorMittal
MT
|
+$3.78M |
| 4 |
STMicroelectronics
STM
|
+$3.26M |
| 5 |
Industrial Select Sector SPDR Fund
XLI
|
+$2.93M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$56.8M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$33.3M |
| 3 |
Utilities Select Sector SPDR Fund
XLU
|
+$10.1M |
| 4 |
Goldman Sachs
GS
|
+$8.36M |
| 5 |
Energy Transfer Partners
ET
|
+$7.98M |
Sector Composition
| 1 | Technology | 26.89% |
| 2 | Financials | 11.73% |
| 3 | Consumer Staples | 9.84% |
| 4 | Healthcare | 7.74% |
| 5 | Consumer Discretionary | 5.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Vertex Pharmaceuticals
VRTX
$101B
| $4.85K | ﹤0.01% |
10
-32
| -76% | -$15.5K |
|
477
Twist Bioscience
TWST
$1.49B
| $4.79K | ﹤0.01% |
+122
| New | +$4.79K |
|
478
Veracyte
VCYT
$2.5B
| $4.69K | ﹤0.01% |
+158
| New | +$4.69K |
|
479
Hudson Technologies
HDSN
$436M
| $4.55K | ﹤0.01% |
+737
| New | +$4.55K |
|
480
Melco Resorts & Entertainment
MLCO
$3.78B
| $4.47K | ﹤0.01% |
849
-5,051
| -86% | -$26.6K |
|
481
Mirum Pharmaceuticals
MIRM
$3.83B
| $4.46K | ﹤0.01% |
+99
| New | +$4.46K |
|
482
FormFactor
FORM
$2.3B
| $4.44K | ﹤0.01% |
+157
| New | +$4.44K |
|
483
Progress Software
PRGS
$1.85B
| $4.43K | ﹤0.01% |
+86
| New | +$4.43K |
|
484
iQIYI
IQ
$2.69B
| $4.37K | ﹤0.01% |
1,934
-7,246
| -79% | -$16.4K |
|
485
Edgewise Therapeutics
EWTX
$1.58B
| $4.36K | ﹤0.01% |
+198
| New | +$4.36K |
|
486
Appian
APPN
$2.38B
| $4.35K | ﹤0.01% |
+151
| New | +$4.35K |
|
487
TTM Technologies
TTMI
$4.8B
| $4.25K | ﹤0.01% |
+207
| New | +$4.25K |
|
488
SM Energy
SM
$3.07B
| $4.22K | ﹤0.01% |
+141
| New | +$4.22K |
|
489
FIVE9
FIVN
$2.04B
| $4.21K | ﹤0.01% |
+155
| New | +$4.21K |
|
490
Bank of America
BAC
$372B
| $4.17K | ﹤0.01% |
100
-17,800
| -99% | -$743K |
|
491
NextDecade
NEXT
$2.69B
| $4.17K | ﹤0.01% |
+536
| New | +$4.17K |
|
492
NovoCure
NVCR
$1.4B
| $4.13K | ﹤0.01% |
+232
| New | +$4.13K |
|
493
First Merchants
FRME
$2.34B
| $4.13K | ﹤0.01% |
+102
| New | +$4.13K |
|
494
CG Oncology
CGON
$2.49B
| $3.99K | ﹤0.01% |
+163
| New | +$3.99K |
|
495
Playtika
PLTK
$1.43B
| $3.9K | ﹤0.01% |
+754
| New | +$3.9K |
|
496
Kymera Therapeutics
KYMR
$3.15B
| $3.83K | ﹤0.01% |
+140
| New | +$3.83K |
|
497
JetBlue
JBLU
$1.89B
| $3.67K | ﹤0.01% |
+761
| New | +$3.67K |
|
498
Criteo
CRTO
$1.22B
| $3.58K | ﹤0.01% |
+101
| New | +$3.58K |
|
499
Upwork
UPWK
$2.11B
| $3.58K | ﹤0.01% |
+274
| New | +$3.58K |
|
500
OneSpaWorld
OSW
$2.27B
| $3.44K | ﹤0.01% |
+205
| New | +$3.44K |
|